Latest News – 17 September 2024

Influenza Vaccines

Cumulative numbers of released influenza vaccine doses 2024/2025
(as of 15 September 2024)

International Work

Delegation from Africa Visits the Paul-Ehrlich-Institut

Medicinal Product Supply

Paul-Ehrlich-Institut approves import of Beyfortus for the German market

Press Releases

Research at the Paul-Ehrlich-Institut: Findings on Natural Anticoagulants in Treatment of COVID-19

Information on the Topic of Vaccination Damages

The Paul-Ehrlich-Institut is not responsible for processing applications for recognition of vaccine damages.

The Paul-Ehrlich-Institut does not have any information, figures/data on vaccine damage procedures.

Recognition procedures for vaccination damages in accordance with section 24 of the Social Code (Sozialgesetzbuch, SGB) XIV are handled exclusively by the Social Welfare Office in the federal state in whose territory the vaccination was carried out. Sections 4, 5 and 113 of the SGB XIV provide information on the competent authority, compensation for official measures and payment obligations.

Important Short Links for Your Research

• Da­ta on suspected Ad­verse Drug Re­ac­tions
  www.pei.de/adr-data
• COVID-19 safety reports:
  www.pei.de/safety-covid-19-vaccines
• COVID-19 vaccines (with link to product information):
  www.pei.de/covid-19-vaccines
• Corona FAQ (including approval and development, efficacy and safety, batch testing and antigen testing):
  www.pei.de/faq-coronavirus-en
• Explainer videos as well as recordings of press briefings:
  www.youtube.com/channel/UC0GDU8v6JtuozYQqfjJN8bg/videos

top